Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...

A hidden chunk of an ancient tectonic plate is stuck to the Pacific Ocean floor and sliding under North America, complicating ...

JUNCTION CITY, Kan. (WIBW) - Kansas health officials have issued a boil water advisory for a portion of the Junction City public water supply system on Wednesday, Nov. 12. The Kansas Dept. of Health ...

This study presents a valuable finding on a new role of glia in activity-dependent synaptic remodeling using the Drosophila NMJ as a model system. The evidence supporting the claims of the authors is ...

International Tennis Hall of Famer Monica Seles announced this week that she was diagnosed 3 years ago with myasthenia gravis (MG), a chronic autoimmune disease that causes muscle weakness. Speaking ...

NEUROMUSCULAR diseases, while rare, can be debilitating and even fatal for patients if left untreated. Although some treatments do exist, long-term evidence is lacking, and physiological barriers ...

Adam Taylor does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

COLUMBUS, Ohio, Aug. 21, 2025 /PRNewswire/ -- Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered ...

iDEAL Semiconductor is now sampling the first products in its new series of silicon MOSFETs that leverage its SuperQ architecture to deliver efficiencies and performance that rival some compound ...

Findings published in The American Journal of Pathology identify GLUD1 enzyme as a potential therapeutic target for muscle restoration through metabolic reprogramming, addressing clinically unmet need ...

Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major antibody categories: those to the acetylcholine receptor (AChR antibodies), ...

In myasthenia gravis, complement plays a big role in what happens to the muscle end of the neuromuscular junction, explains Miriam Freimer, MD, an author on 5 abstracts presented at the recent 15th ...